Sign in
Is It Necessary to Peel Internal Limiting Membrane in Diabetic Vitrectomy
Stanley Chang, MD
Updates from the Field
2022
Baseline Characteristics of Patients Who Did or Did Not Maintain 12-Week and 16-Week Aflibercept 8 mg Dosing Intervals in the Phase 2/3 PHOTON Trial
Eric W Schneider, MD
Annual Meeting Talks
2023
Longitudinal Macular Thickness and Microvascular Changes in Children with Sickle Cell Disease
Adrienne W. Scott, MD, FASRS
Category: Imaging